Biomarkers for neurodegenerative diseases
Top Cited Papers
- 3 June 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 27 (6), 954-963
- https://doi.org/10.1038/s41591-021-01382-x
Abstract
Biomarkers for neurodegenerative diseases are needed to improve the diagnostic workup in the clinic but also to facilitate the development and monitoring of effective disease-modifying therapies. Positron emission tomography methods detecting amyloid-β and tau pathology in Alzheimer’s disease have been increasingly used to improve the design of clinical trials and observational studies. In recent years, easily accessible and cost-effective blood-based biomarkers detecting the same Alzheimer’s disease pathologies have been developed, which might revolutionize the diagnostic workup of Alzheimer’s disease globally. Relevant biomarkers for α-synuclein pathology in Parkinson’s disease are also emerging, as well as blood-based markers of general neurodegeneration and glial activation. This review presents an overview of the latest advances in the field of biomarkers for neurodegenerative diseases. Future directions are discussed regarding implementation of novel biomarkers in clinical practice and trials.Keywords
This publication has 148 references indexed in Scilit:
- 100 years of Lewy pathologyNature Reviews Neurology, 2012
- Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010Journal of Neuropathology and Experimental Neurology, 2012
- The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeuticsNature Reviews Drug Discovery, 2011
- Mild Cognitive ImpairmentThe New England Journal of Medicine, 2011
- Imaging Approaches to Parkinson DiseaseJournal of Nuclear Medicine, 2010
- Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's diseaseAlzheimer's Research & Therapy, 2010
- Missed and Delayed Diagnosis of Dementia in Primary CareAlzheimer Disease & Associated Disorders, 2009
- Age, Neuropathology, and DementiaThe New England Journal of Medicine, 2009
- Measuring target effect of proposed disease-modifying therapies in Alzheimer’s diseaseNeurotherapeutics, 2008
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002